Lv1
58 积分 2024-09-07 加入
Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review
11天前
已完结
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
11天前
已完结
Dissecting the clinicopathologic, genomic, and prognostic significance of anaplastic lymphoma kinase rearrangement in resected lung adenocarcinoma
21天前
已完结
Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to Alectinib
27天前
已关闭
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
29天前
已完结
A Case of Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion with Partial Response to Crizotinib
29天前
已完结
PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors
29天前
已完结
Small cell lung cancer transformation: From pathogenesis to treatment
30天前
已完结
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
1个月前
已完结
Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One
1个月前
已完结
皖公网安备34019202002308
